Chemclin's HIV kits for in-vitro qualitative determination of Anti-HIV 1+2

Published on July 22, 2014 at 7:21 AM · No Comments

Chemclin's HIV kits are available for in-vitro qualitative determination of Antibody to Human Immunodeficiency Virus Type 1 and Type 2 (Anti-HIV 1+2) and P24 antigen of HIV in human serum or plasma by a sandwich chemiluminescent assay method.

Chemclin's HIV CLIA assays have been awarded as the first-class products for HIV CLIA tests for years by the Ministry of Science and Technology in China and the National Center for AIDS/STD Control and Prevention of Chinese Center for Disease Control and Prevention (China AIDS).

Acquired Immune Deficiency Syndrome (AIDS) is a serious disease caused by Human Immunodeficiency Virus. People may be infected through three ways: sexual behaviors, blood transfusion and mother-to-infant spread. Detection of Anti-HIV (1+2) antibody and P24 antigen of HIV in human serum or plasma will assist in the diagnosis of HIV infection.



Posted in: Medical Research News | Disease/Infection News

Tags: , , , , , , , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
CDC guidelines for PrEP use to prevent HIV transmission do not go far enough, UCLA study suggests